Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001415889-25-000595

CHIEF FINANCIAL OFFICER acquired 431,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Alam Kamran CHIEF FINANCIAL OFFICER 2025-01-02 Grant or award +431,000 1,271,937 D
Derivatives
Alam Kamran CHIEF FINANCIAL OFFICER 2025-01-02 Grant or award · Employee Stock Option (right to buy) +431,000 431,000 D
Loading xslF345X05/form4-01032025_100118.xml…